{"id":3978,"date":"2017-08-13T07:38:59","date_gmt":"2017-08-13T07:38:59","guid":{"rendered":"https:\/\/andromedichyperthermia.com\/andromedic-esho-2014\/"},"modified":"2026-02-17T10:03:26","modified_gmt":"2026-02-17T10:03:26","slug":"andromedic-esho-2014","status":"publish","type":"page","link":"https:\/\/andromedichyperthermia.com\/hr\/andromedic-esho-2014\/","title":{"rendered":"Europsko dru\u0161tvo za hipertermijsku onkologiju\u00a0 ESHO 2014 &#8211; Andromedic intervencija"},"content":{"rendered":"<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": \"MedicalWebPage\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/cs\/andromedic-esho-2014\/#webpage\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/cs\/andromedic-esho-2014\/\",\n      \"name\": \"Klinick\u00e9 studie s Andromedic HyDeep 600 WM - Kongres ESHO\",\n      \"description\": \"Data z klinick\u00fdch studi\u00ed syst\u00e9mu HyDeep 600 WM pro karcinom d\u011blo\u017en\u00edho \u010d\u00edpku a multicentrick\u00e9 studie proveditelnosti prezentovan\u00e9 na kongresu ESHO.\",\n      \"inLanguage\": \"cs-CZ\",\n      \"isPartOf\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#website\" },\n      \"mainEntity\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\" },\n      \"about\": [\n        {\n          \"@type\": \"MedicalStudy\",\n          \"name\": \"Studie LACC u karcinomu d\u011blo\u017en\u00edho \u010d\u00edpku\",\n          \"description\": \"Studie na 8 pacientech prokazuj\u00edc\u00ed 100% lok\u00e1ln\u00ed kontrolu p\u0159i pou\u017eit\u00ed syst\u00e9mu HyDeep 600 WM a HDR brachyterapie.\",\n          \"studySubject\": { \"@type\": \"MedicalCondition\", \"name\": \"Rakovina d\u011blo\u017en\u00edho \u010d\u00edpku\" }\n        },\n        {\n          \"@type\": \"MedicalStudy\",\n          \"name\": \"P\u0159\u00edpadov\u00e1 studie ve \u0160pan\u011blsku\",\n          \"description\": \"Rozs\u00e1hl\u00e1 studie proveditelnosti s 293 pacienty zahrnuj\u00edc\u00ed 9 typ\u016f n\u00e1dor\u016f.\",\n          \"sampleSize\": 293,\n          \"studyStatus\": \"Published\"\n        }\n      ],\n      \"mentions\": [\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-salvatore-conte\/\" },\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" }\n      ]\n    },\n    {\n      \"@type\": [\"Product\", \"MedicalDevice\"],\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\",\n      \"name\": \"HyDeep 600WM\",\n      \"brand\": { \"@type\": \"Brand\", \"name\": \"Andromedic\" },\n      \"image\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/HyDeep-600WM-Andromedic.jpg\",\n      \"description\": \"Pokro\u010dil\u00fd syst\u00e9m pro onkologickou hypertermii \/ profesion\u00e1ln\u00ed za\u0159\u00edzen\u00ed pro modulovanou RF hypertermii (13,56 MHz) pro lok\u00e1ln\u00ed hlubokou hypertermii.\",\n      \"offers\": {\n        \"@type\": \"Offer\",\n        \"price\": \"0\",\n        \"priceCurrency\": \"EUR\",\n        \"availability\": \"https:\/\/schema.org\/InStock\",\n        \"url\": \"https:\/\/andromedichyperthermia.com\/cs\/contact\/\",\n        \"priceSpecification\": {\n          \"@type\": \"PriceSpecification\",\n          \"description\": \"Cena na vy\u017e\u00e1d\u00e1n\u00ed\"\n        }\n      },\n      \"review\": {\n        \"@type\": \"Review\",\n        \"author\": { \"@type\": \"Person\", \"name\": \"Dr. med. Veronica Iatan\" },\n        \"reviewRating\": { \"@type\": \"Rating\", \"ratingValue\": \"5\", \"bestRating\": \"5\" },\n        \"reviewBody\": \"\u0160pi\u010dkov\u00e1 technologie pro hlubokou hypertermii s klinicky ov\u011b\u0159en\u00fdmi protokoly.\"\n      }\n    },\n    {\n      \"@type\": \"MedicalOrganization\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\",\n      \"name\": \"Andromedic Srl\"\n    }\n  ]\n}\n<\/script><\/p>\n<div style=\"line-height: 1.6; color: #333; max-width: 1100px; margin: auto; font-family: 'Segoe UI', Helvetica, sans-serif; background-color: #fff; padding: 20px;\">\n<header style=\"border-bottom: 4px solid #1a2a6c; padding-bottom: 25px; margin-bottom: 40px; text-align: center;\">\n<h1 style=\"color: #1a2a6c; font-size: 28px; font-weight: 800; text-transform: uppercase; margin-bottom: 10px;\">Europsko dru\u0161tvo za hipertermijsku onkologiju: ESHO 2014<\/h1>\n<h2 style=\"color: #b21f1f; font-size: 20px; font-weight: 600;\">Intervencija Andromedic \u2013 Dr. Salvatore Conte<\/h2>\n<p style=\"font-size: 16px; max-width: 850px; margin: 15px auto; color: #555;\">Na kongresu <a style=\"color: #1a2a6c; text-decoration: none; font-weight: bold;\" href=\"http:\/\/esho.info\" target=\"_blank\" rel=\"noopener\">ESHO 2014<\/a>, <a style=\"color: #1a2a6c; text-decoration: none;\" href=\"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-salvatore-conte\/\"><strong>dr. Salvatore Conte<\/strong><\/a> objavio je zna\u010dajnu prekretnicu za Andromedic tim: uspje\u0161nu proizvodnju i isporuku 25 <a style=\"color: #1a2a6c; text-decoration: none;\" href=\"https:\/\/andromedichyperthermia.com\/hr\/uredaj-za-hipertermiju-rf-onkolosku\/\"><strong>HyDeep 600WM<\/strong> ure\u0111aja za duboku lokalnu hipertermiju<\/a> u samo 18 mjeseci, uz dodatnih 40 jedinica namijenjenih Indiji.<\/p>\n<\/header>\n<div style=\"margin-bottom: 50px; border-radius: 15px; overflow: hidden; box-shadow: 0 10px 25px rgba(0,0,0,0.2);\">\n<p><iframe loading=\"lazy\" title=\"intervento Andromedic   Esho 20014\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/fgMdXxoJ1cI?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n<\/div>\n<h2 style=\"text-align: center; color: #1a2a6c; margin-bottom: 30px; text-transform: uppercase; font-weight: bold;\">Prezentirana klini\u010dka ispitivanja: HyDeep 600 WM napredna onkolo\u0161ka hipertermija<\/h2>\n<section style=\"margin-bottom: 50px; border: 1px solid #e1e8ed; border-radius: 15px; overflow: hidden; box-shadow: 0 5px 15px rgba(0,0,0,0.05);\">\n<div style=\"background: #1a2a6c; color: #fff; padding: 20px;\">\n<h3 style=\"margin: 0; font-size: 19px;\">1. Kemoradioterapija + Hipertermija + HDR Brahiterapija za LACC<\/h3>\n<\/div>\n<div style=\"padding: 30px; background: #f9f9f9;\"><strong>CILJEVI:<\/strong> Istra\u017eiti ishod kombinacije tjednog cisplatina i duboke lokalne hipertermije s IMRT-om, nakon \u010dega slijedi BRT za lokalno uznapredovali karcinom vrata maternice (LACC).<\/p>\n<div style=\"background: #fff; padding: 20px; border-radius: 10px; margin: 20px 0; border-left: 5px solid #b21f1f;\"><strong>MATERIJALI I METODE:<\/strong><\/p>\n<ul style=\"margin-top: 10px; font-size: 15px; list-style-type: disc; padding-left: 20px;\">\n<li><strong>Skupina pacijenata:<\/strong> 8 pacijenata (3 stadij IIB, 1 IIIB, 2 NEI, 3 LRCC).<\/li>\n<li><strong>Protokol:<\/strong> 50.4 Gy na zdjeli\u010dne \u010dvorove sa SIB-om na GTV (ukupno 61.8 Gy) u 28 frakcija. Doza BRT-a: 21 Gy u 3 frakcije.<\/li>\n<li><strong>Istodobna terapija:<\/strong> Tjedni Cisplatin 40mg\/m\u00b2 + HT jednom tjedno.<\/li>\n<\/ul>\n<\/div>\n<div style=\"background: #e8f5e9; padding: 20px; border-radius: 10px; border: 1px solid #2e7d32;\"><strong style=\"color: #1b5e20; font-size: 17px; display: block; margin-bottom: 10px;\">REZULTATI I ZAKLJU\u010cCI:<\/strong><\/p>\n<p style=\"font-size: 16px; font-weight: bold; margin: 0; color: #1b5e20;\">POSTIGNUTA 100% LOKALNA KONTROLA. Nije uo\u010dena akutna ili kasna toksi\u010dnost stupnja 3 do 4 povezana s lije\u010denjem.<\/p>\n<p style=\"margin-top: 10px; font-style: italic; color: #2e7d32;\">&#8220;Dodatak duboke lokalne hipertermije kemoradioterapiji predstavlja obe\u0107avaju\u0107u novu strategiju s izvrsnom tolerancijom.&#8221;<\/p>\n<\/div>\n<\/div>\n<\/section>\n<section style=\"margin-bottom: 50px; border: 1px solid #e1e8ed; border-radius: 15px; overflow: hidden; box-shadow: 0 5px 15px rgba(0,0,0,0.05);\">\n<div style=\"background: #b21f1f; color: #fff; padding: 20px;\">\n<h3 style=\"margin: 0; font-size: 19px;\">2. Studija izvedivosti (Case-Control) \u2013 duboka lokalna hipertermija &#8211; Andaluzija, \u0160panjolska<\/h3>\n<\/div>\n<div style=\"padding: 30px;\"><strong>Uvod:<\/strong> Prvo klini\u010dko ispitivanje u \u0160panjolskoj koje kombinira duboku lokalnu hipertermiju sa standardnim onkolo\u0161kim tretmanima unutar javnog zdravstvenog sustava.<\/p>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit, minmax(250px, 1fr)); gap: 20px; margin: 25px 0;\">\n<div style=\"background: #f0f4f8; padding: 15px; border-radius: 10px; border-top: 4px solid #1a2a6c;\"><strong>Dizajn ispitivanja:<\/strong> Prospektivna, kontrolirana studija. Ukupno 293 pacijenta (97 u aktivnoj fazi vs. 196 kontrola). 9 lokacija tumora.<\/div>\n<div style=\"background: #f0f4f8; padding: 15px; border-radius: 10px; border-top: 4px solid #1a2a6c;\"><strong>Parametri lije\u010denja:<\/strong> 10 sesija (2-3 tjedno), trajanje 1 sat, 150W\u2013400W koriste\u0107i <strong>HyDeep 600WM sustav za moduliranu hipertermiju<\/strong>.<\/div>\n<\/div>\n<h4 style=\"color: #1a2a6c; border-bottom: 2px solid #b21f1f; display: inline-block; padding-bottom: 5px; font-weight: bold;\">Preliminarni podaci (podskup od 22 pacijenta):<\/h4>\n<ul style=\"margin-top: 15px; font-size: 14px; column-count: 2; padding-left: 20px;\">\n<li><strong>Glioblastom (2c)<\/strong><\/li>\n<li><strong>Glava i vrat (7c)<\/strong><\/li>\n<li><strong>Preoperativni rektum (3c)<\/strong><\/li>\n<li><strong>Rak dojke (3c)<\/strong><\/li>\n<li><strong>Plu\u0107a (NSCLC &#8211; 11c)<\/strong><\/li>\n<li><strong>Prostata (4c)<\/strong><\/li>\n<li><strong>Cerviks i metastaze<\/strong><\/li>\n<\/ul>\n<div style=\"display: flex; flex-wrap: wrap; gap: 15px; margin: 25px 0;\">\n<div style=\"flex: 1; min-width: 200px; background: #fffde7; padding: 20px; border-radius: 10px; text-align: center; border: 1px solid #fbc02d;\"><span style=\"font-size: 28px; font-weight: 800; display: block; color: #f57f17;\">81.2%<\/span><br \/>\n<strong>VISOKA TOLERANCIJA<\/strong><\/p>\n<p><small>Pacijenti zadovoljni ili vrlo zadovoljni<\/small><\/div>\n<div style=\"flex: 1; min-width: 200px; background: #f1f8e9; padding: 20px; border-radius: 10px; text-align: center; border: 1px solid #7cb342;\"><span style=\"font-size: 28px; font-weight: 800; display: block; color: #388e3c;\">66.6%<\/span><br \/>\n<strong>NULTA TOKSI\u010cNOST<\/strong><\/p>\n<p><small>Nisu zabilje\u017eene nuspojave<\/small><\/div>\n<\/div>\n<p style=\"background: #f4f7f9; padding: 15px; border-radius: 8px; border-left: 4px solid #1a2a6c;\"><strong>ZAKLJU\u010cAK:<\/strong> Duboka lokalna hipertermija je izvediva u rutinskoj njezi u javnim bolnicama bez izvanrednih resursa. Pravilan odabir pacijenata osigurava minimalnu toksi\u010dnost (stupanj 1).<\/p>\n<div style=\"text-align: center; margin-top: 30px;\"><a style=\"display: inline-block; background: #b21f1f; color: #fff; padding: 14px 30px; text-decoration: none; border-radius: 5px; font-weight: 800; text-transform: uppercase; box-shadow: 0 4px 10px rgba(178,31,31,0.3);\" href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Protocolo-del-ensayo-MAG-HIP-2013-01-11-EN.pdf\">Preuzmite cijeli protokol studije (PDF)<\/a><\/div>\n<\/div>\n<\/section>\n<div style=\"margin-top: 40px;\">\n<h3 style=\"text-align: center; color: #1a2a6c; text-transform: uppercase; letter-spacing: 1px; font-weight: bold;\">ESHO znanstveni posteri i dokumentacija<\/h3>\n<div id='gallery-1' class='gallery galleryid-3978 gallery-columns-1 gallery-size-full'><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/hr\/klinicka-istrazivanja\/preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma-2\/\"><img loading=\"lazy\" decoding=\"async\" width=\"590\" height=\"837\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma.jpg\" class=\"attachment-full size-full\" alt=\"\" aria-describedby=\"gallery-1-1325\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma.jpg 590w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma-211x300.jpg 211w\" sizes=\"auto, (max-width: 590px) 100vw, 590px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-1325'>\n\t\t\t\tPreliminary results of chemoradiation plus Andromedic hyperthermia and high dose rate brachytherapy for locally advanced cervical carcinoma\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/hr\/klinicka-istrazivanja\/quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-b-2\/\"><img loading=\"lazy\" decoding=\"async\" width=\"569\" height=\"831\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B.jpg\" class=\"attachment-full size-full\" alt=\"\" aria-describedby=\"gallery-1-1304\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B.jpg 569w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B-205x300.jpg 205w\" sizes=\"auto, (max-width: 569px) 100vw, 569px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-1304'>\n\t\t\t\tQuasi feasibility study(case control) asscoaiting deep local hyperthermia treatment with standard cancer treatments and describing patterns of response ESHO\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/hr\/klinicka-istrazivanja\/quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-2\/\"><img loading=\"lazy\" decoding=\"async\" width=\"568\" height=\"826\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response.jpg\" class=\"attachment-full size-full\" alt=\"\" aria-describedby=\"gallery-1-1283\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response.jpg 568w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-206x300.jpg 206w\" sizes=\"auto, (max-width: 568px) 100vw, 568px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-1283'>\n\t\t\t\tQuasi feasibility study(case control) associating deep local hyperthermia HyDeep 600WM treatment with standard cancer treatments and describing patterns of response\n\t\t\t\t<\/figcaption><\/figure>\n\t\t<\/div>\n\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Europsko dru\u0161tvo za hipertermijsku onkologiju: ESHO 2014 Intervencija Andromedic \u2013 Dr. Salvatore Conte Na kongresu ESHO 2014, dr. Salvatore Conte objavio je zna\u010dajnu prekretnicu za Andromedic tim: uspje\u0161nu proizvodnju i isporuku 25 HyDeep 600WM ure\u0111aja za duboku lokalnu hipertermiju u samo 18 mjeseci, uz dodatnih 40 jedinica namijenjenih Indiji. Prezentirana klini\u010dka ispitivanja: HyDeep 600 WM&hellip;<\/p>\n","protected":false},"author":1,"featured_media":17337,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-gutentor-full-width.php","meta":{"footnotes":""},"class_list":["post-3978","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/andromedichyperthermia.com\/hr\/wp-json\/wp\/v2\/pages\/3978","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andromedichyperthermia.com\/hr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/andromedichyperthermia.com\/hr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/hr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/hr\/wp-json\/wp\/v2\/comments?post=3978"}],"version-history":[{"count":0,"href":"https:\/\/andromedichyperthermia.com\/hr\/wp-json\/wp\/v2\/pages\/3978\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/hr\/wp-json\/wp\/v2\/media\/17337"}],"wp:attachment":[{"href":"https:\/\/andromedichyperthermia.com\/hr\/wp-json\/wp\/v2\/media?parent=3978"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}